Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 16 studies with search of: | Senegal |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Completed |
ATAQ EASY: Artesunate + Amodiaquine Fixed Dose Combination in the Treatment of Uncomplicated Plasmodium Falciparum Malaria
|
||||
2 | Completed |
Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)
|
||||
3 | Recruiting |
Identifying Genes That Predict Risk of Developing Cervical Intraepithelial Neoplasia or Invasive Cervical Cancer
|
||||
4 | Recruiting |
Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)
|
||||
5 | Completed |
Investigation of a Novel Approach to Improve Treatment Success Rates for Tuberculosis Patients in Senegal
|
||||
6 | Recruiting |
Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks
|
||||
7 | Completed |
Three Alternative Drug Regimens for Malaria Seasonal Preventive Treatment in Senegal
|
||||
8 | Completed |
A Trial of Four Drug Regimens for the Prevention of Malaria in Senegalese Children
|
||||
9 | Completed |
Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria.
|
||||
10 | Completed |
A Trial of Intermittent Treatment in the Prevention of Malaria in Senegalese Children
|
||||
11 | Recruiting |
Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine 580299 in Healthy Females 10 - 25 Years of Age.
|
||||
12 | Active, not recruiting |
A Phase I Study of a New Tuberculosis (TB) Vaccine, MVA85A, in Healthy Volunteers With HIV
|
||||
13 | Completed |
Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients
|
||||
14 | Recruiting |
A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment of Pulmonary Tuberculosis
|
||||
15 | Terminated |
Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2)
|
||||
16 | Completed |
Arsucam® (Artesunate + Amiodaquine) Efficacy and TOLerance
|